Pentoxifylline attenuation of experimental hepatopulmonary syndrome

Junlan Zhang, Yiqun Ling, Liping Tang, Bao Luo, Balu K. Chacko, Rakesh P. Patel, Michael B. Fallon

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Hepatopulmonary syndrome (HPS) following rat common bile duct ligation results from pulmonary molecular changes that may be influenced by circulating TNF-α and increased vascular shear stress, through activation of NF-κB or Akt. Increased pulmonary microvascular endothelin B (ET B) receptor and endothelial nitric oxide synthase (eNOS) levels contribute to nitric oxide production and the development of experimental HPS. Pentoxifylline (PTX), a phosphodiesterase and nonspecific TNF-α inhibitor, ameliorates experimental HPS when begun before hepatic injury. However, how PTX influences the molecular events associated with initiation of experimental HPS after liver injury is established is unknown. We assessed the effects of PTX on the molecular and physiological features of HPS in vivo and on shear stress or TNF-α-mediated events in rat pulmonary microvascular endothelial cells in vitro. PTX significantly improved HPS without altering portal or systemic hemodynamics and downregulated pulmonary ETB receptor levels and eNOS expression and activation. These changes were associated with a reduction in circulating TNF levels and NF-αB activation and complete inhibition of Akt activation. In rat pulmonary microvascular endothelial cells, PTX inhibited shear stress-induced ETB receptor and eNOS expression and eNOS activation. These effects were also associated with inhibition of Akt activation and were reproduced by wortmanin. In contrast, TNF-α had no effects on endothelial ETB and eNOS alterations in vitro. PTX has direct effects in the pulmonary microvasculature, likely mediated through Akt inhibition, that ameliorate experimental HPS.

Original languageEnglish (US)
Pages (from-to)949-955
Number of pages7
JournalJournal of Applied Physiology
Volume102
Issue number3
DOIs
StatePublished - Mar 1 2007
Externally publishedYes

Fingerprint

Hepatopulmonary Syndrome
Pentoxifylline
Nitric Oxide Synthase Type III
Lung
Endothelial Cells
Endothelin B Receptors
Liver
Phosphoric Diester Hydrolases
Wounds and Injuries
Common Bile Duct
Microvessels
Ligation
Blood Vessels
Nitric Oxide
Down-Regulation
Hemodynamics

Keywords

  • Common bile duct ligation
  • Endothelial cells
  • Endothelial nitric oxide synthase
  • Endothelin B receptor

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Pentoxifylline attenuation of experimental hepatopulmonary syndrome. / Zhang, Junlan; Ling, Yiqun; Tang, Liping; Luo, Bao; Chacko, Balu K.; Patel, Rakesh P.; Fallon, Michael B.

In: Journal of Applied Physiology, Vol. 102, No. 3, 01.03.2007, p. 949-955.

Research output: Contribution to journalArticle

Zhang, Junlan ; Ling, Yiqun ; Tang, Liping ; Luo, Bao ; Chacko, Balu K. ; Patel, Rakesh P. ; Fallon, Michael B. / Pentoxifylline attenuation of experimental hepatopulmonary syndrome. In: Journal of Applied Physiology. 2007 ; Vol. 102, No. 3. pp. 949-955.
@article{3baf0c82a85f41d496d4c2a19d61ee0a,
title = "Pentoxifylline attenuation of experimental hepatopulmonary syndrome",
abstract = "Hepatopulmonary syndrome (HPS) following rat common bile duct ligation results from pulmonary molecular changes that may be influenced by circulating TNF-α and increased vascular shear stress, through activation of NF-κB or Akt. Increased pulmonary microvascular endothelin B (ET B) receptor and endothelial nitric oxide synthase (eNOS) levels contribute to nitric oxide production and the development of experimental HPS. Pentoxifylline (PTX), a phosphodiesterase and nonspecific TNF-α inhibitor, ameliorates experimental HPS when begun before hepatic injury. However, how PTX influences the molecular events associated with initiation of experimental HPS after liver injury is established is unknown. We assessed the effects of PTX on the molecular and physiological features of HPS in vivo and on shear stress or TNF-α-mediated events in rat pulmonary microvascular endothelial cells in vitro. PTX significantly improved HPS without altering portal or systemic hemodynamics and downregulated pulmonary ETB receptor levels and eNOS expression and activation. These changes were associated with a reduction in circulating TNF levels and NF-αB activation and complete inhibition of Akt activation. In rat pulmonary microvascular endothelial cells, PTX inhibited shear stress-induced ETB receptor and eNOS expression and eNOS activation. These effects were also associated with inhibition of Akt activation and were reproduced by wortmanin. In contrast, TNF-α had no effects on endothelial ETB and eNOS alterations in vitro. PTX has direct effects in the pulmonary microvasculature, likely mediated through Akt inhibition, that ameliorate experimental HPS.",
keywords = "Common bile duct ligation, Endothelial cells, Endothelial nitric oxide synthase, Endothelin B receptor",
author = "Junlan Zhang and Yiqun Ling and Liping Tang and Bao Luo and Chacko, {Balu K.} and Patel, {Rakesh P.} and Fallon, {Michael B.}",
year = "2007",
month = "3",
day = "1",
doi = "10.1152/japplphysiol.01048.2006",
language = "English (US)",
volume = "102",
pages = "949--955",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Pentoxifylline attenuation of experimental hepatopulmonary syndrome

AU - Zhang, Junlan

AU - Ling, Yiqun

AU - Tang, Liping

AU - Luo, Bao

AU - Chacko, Balu K.

AU - Patel, Rakesh P.

AU - Fallon, Michael B.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Hepatopulmonary syndrome (HPS) following rat common bile duct ligation results from pulmonary molecular changes that may be influenced by circulating TNF-α and increased vascular shear stress, through activation of NF-κB or Akt. Increased pulmonary microvascular endothelin B (ET B) receptor and endothelial nitric oxide synthase (eNOS) levels contribute to nitric oxide production and the development of experimental HPS. Pentoxifylline (PTX), a phosphodiesterase and nonspecific TNF-α inhibitor, ameliorates experimental HPS when begun before hepatic injury. However, how PTX influences the molecular events associated with initiation of experimental HPS after liver injury is established is unknown. We assessed the effects of PTX on the molecular and physiological features of HPS in vivo and on shear stress or TNF-α-mediated events in rat pulmonary microvascular endothelial cells in vitro. PTX significantly improved HPS without altering portal or systemic hemodynamics and downregulated pulmonary ETB receptor levels and eNOS expression and activation. These changes were associated with a reduction in circulating TNF levels and NF-αB activation and complete inhibition of Akt activation. In rat pulmonary microvascular endothelial cells, PTX inhibited shear stress-induced ETB receptor and eNOS expression and eNOS activation. These effects were also associated with inhibition of Akt activation and were reproduced by wortmanin. In contrast, TNF-α had no effects on endothelial ETB and eNOS alterations in vitro. PTX has direct effects in the pulmonary microvasculature, likely mediated through Akt inhibition, that ameliorate experimental HPS.

AB - Hepatopulmonary syndrome (HPS) following rat common bile duct ligation results from pulmonary molecular changes that may be influenced by circulating TNF-α and increased vascular shear stress, through activation of NF-κB or Akt. Increased pulmonary microvascular endothelin B (ET B) receptor and endothelial nitric oxide synthase (eNOS) levels contribute to nitric oxide production and the development of experimental HPS. Pentoxifylline (PTX), a phosphodiesterase and nonspecific TNF-α inhibitor, ameliorates experimental HPS when begun before hepatic injury. However, how PTX influences the molecular events associated with initiation of experimental HPS after liver injury is established is unknown. We assessed the effects of PTX on the molecular and physiological features of HPS in vivo and on shear stress or TNF-α-mediated events in rat pulmonary microvascular endothelial cells in vitro. PTX significantly improved HPS without altering portal or systemic hemodynamics and downregulated pulmonary ETB receptor levels and eNOS expression and activation. These changes were associated with a reduction in circulating TNF levels and NF-αB activation and complete inhibition of Akt activation. In rat pulmonary microvascular endothelial cells, PTX inhibited shear stress-induced ETB receptor and eNOS expression and eNOS activation. These effects were also associated with inhibition of Akt activation and were reproduced by wortmanin. In contrast, TNF-α had no effects on endothelial ETB and eNOS alterations in vitro. PTX has direct effects in the pulmonary microvasculature, likely mediated through Akt inhibition, that ameliorate experimental HPS.

KW - Common bile duct ligation

KW - Endothelial cells

KW - Endothelial nitric oxide synthase

KW - Endothelin B receptor

UR - http://www.scopus.com/inward/record.url?scp=33847744271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847744271&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.01048.2006

DO - 10.1152/japplphysiol.01048.2006

M3 - Article

C2 - 17110505

AN - SCOPUS:33847744271

VL - 102

SP - 949

EP - 955

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 3

ER -